Approval · Notice of Compliance 30152 · 2023
INVOKAMET: Notice of Compliance 30152
Issued February 17, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30152
- Date
- February 17, 2023
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph.. Product Monograph reformatted to the master template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INVOKAMET | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- CANAGLIFLOZIN 50 MG per TAB
- METFORMIN HYDROCHLORIDE 1,000 MG per TAB
- CANAGLIFLOZIN 150 MG per TAB